A detailed history of Eads & Heald Wealth Management transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Eads & Heald Wealth Management holds 1,663 shares of DGX stock, worth $227,980. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,663
Previous 1,663 -0.0%
Holding current value
$227,980
Previous $227,000 13.66%
% of portfolio
0.12%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$123.78 - $142.11 $9,902 - $11,368
-80 Reduced 4.59%
1,663 $221,000
Q2 2023

Jul 25, 2023

SELL
$130.56 - $146.84 $3,916 - $4,405
-30 Reduced 1.69%
1,743 $245,000
Q1 2023

Apr 21, 2023

SELL
$131.53 - $155.76 $2,630 - $3,115
-20 Reduced 1.12%
1,773 $251,000
Q2 2022

Jul 26, 2022

BUY
$127.07 - $145.39 $1,397 - $1,599
11 Added 0.62%
1,793 $238,000
Q4 2021

Jan 31, 2022

SELL
$140.36 - $173.01 $28,072 - $34,602
-200 Reduced 10.09%
1,782 $308,000
Q3 2021

Oct 27, 2021

SELL
$132.95 - $158.0 $9,971 - $11,850
-75 Reduced 3.65%
1,982 $288,000
Q2 2020

Jul 29, 2020

BUY
$73.34 - $122.61 $150,860 - $252,208
2,057 New
2,057 $234,000
Q1 2020

May 01, 2020

SELL
$75.14 - $115.68 $145,921 - $224,650
-1,942 Closed
0 $0
Q3 2019

Oct 31, 2019

BUY
$97.85 - $107.42 $190,024 - $208,609
1,942 New
1,942 $207,000
Q4 2018

Jan 31, 2019

SELL
$79.75 - $108.38 $213,889 - $290,675
-2,682 Closed
0 $0
Q3 2018

Oct 31, 2018

SELL
$105.42 - $114.99 $15,285 - $16,673
-145 Reduced 5.13%
2,682 $0
Q2 2018

Jul 27, 2018

SELL
$97.35 - $113.14 $74,959 - $87,117
-770 Reduced 21.41%
2,827 $0
Q1 2018

Apr 26, 2018

SELL
$96.42 - $107.88 $19,766 - $22,115
-205 Reduced 5.39%
3,597 $0
Q4 2017

Jan 31, 2018

SELL
$90.86 - $100.24 $50,245 - $55,432
-553 Reduced 12.7%
3,802 $0
Q3 2017

Oct 27, 2017

BUY
$91.96 - $108.35 $400,485 - $471,864
4,355
4,355 $0

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Eads & Heald Wealth Management Portfolio

Follow Eads & Heald Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Eads & Heald Wealth Management with notifications on news.